UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000011677
Receipt number R000013655
Scientific Title Comparison of efficacy and safety of the secondary treatment with increased fesoterodine and with mirabegron combination with 4mg fesoterodine for those who still have moderate or more overactive bladder symptoms after the initial treatment with 4mg fesoterodine: preliminary study
Date of disclosure of the study information 2013/09/17
Last modified on 2022/09/19 08:55:55

No. Disposal Last modified on Item of update
1 Insert 2013/09/07 12:51:33
2 Update 2013/09/07 12:56:46 Anticipated trial start date
3 Update 2018/09/11 10:02:18 Name of primary person or sponsor
Organization
4 Update 2022/09/19 08:55:55 Last follow-up date